Clinical Trial Update: A Phase 1b Study to Evaluate the Safety of XEN-101 [Phase 1]

View source ↗

Summary

A Phase 1b safety study of XEN-101 for obesity has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• XEN-101

Snippet

Sponsor: Xeno Biosciences | Conditions: Obesity | Phase 1 | Status: TERMINATED